| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Sep―17 |
Investigation of the relationship between vascular events and copeptin levels in hospitalized COVID-19 patients |
Aysegul Kirankaya, Levent Deniz, Sevil Tugrul, Sevgi Ozcan, Suat Hayri Kucuk, Zeynep Atam Tasdemir, Ertugrul Okuyan, Irfan Sahin |
| 2 |
[GO] |
2025―Aug―30 |
Development of rapid diagnostic tests for multiplexed detection of COVID-19 and influenza diseases |
Zülal Bilici, Göknur Gizem Dinç, İlkay Göksu Polat, Esin Akçael, Tamer Yağcı |
| 3 |
[GO] |
2025―Mrz―27 |
Pasteur effect in leukocyte energy metabolism of patients with mild, moderate, and severe COVID-19 |
Mesut Ortatatli, Goksemin Fatma Sengul, Tugba Fatsa, Erdim Sertoglu, Hakan Boyunaga, Levent Kenar |
| 4 |
[GO] |
2024―Dez―30 |
Genomic profiling of interferon signaling pathway gene mutations in type 2 diabetic individuals with COVID-19 |
Tuncay Tuluk, Teoman Kankılıç, İlkay Civelek, Dilara Fatma Akın, Mehmet Bankır |
| 5 |
[GO] |
2024―Dez―23 |
The significance of taurine for patients with Crimean-Congo hemorrhagic fever and COVID-19 diseases: a cross-sectional study |
Şimşek Çelik, Hüseyin Aydın, Yusuf Kenan Tekin, Zeynep Ertemur, İlhan Korkmaz, Sefa Yurtbay, Aynur Engin |
| 6 |
[GO] |
2024―Nov―22 |
Decreased plasma gelsolin in the COVID-19-related acute respiratory distress syndrome |
Inayet Gunturk, Gonul Seyda Seydel, Cevat Yazici, Ulas Serkan Topaloglu, Esma Eren, Recep Civan Yuksel |
| 7 |
[GO] |
2024―Okt―24 |
Differential proinflammatory responses of colon epithelial cells to SARS-CoV-2 spike protein and Pseudomonas aeruginosa lipopolysaccharide |
Aysegul Yılmaz, Seyhan Turk, Ümit Yavuz Malkan, İbrahim Celalettin Haznedaroglu, Gulberk Ucar, Sukru Volkan Ozguven, Can Turk |
| 8 |
[GO] |
2024―Sep―03 |
Investigation of SARS-CoV-2 release in fecal specimens of discharge COVID-19 patients |
Arzu Koparan, Süreyya Dede, Nilgün Işıksaçan, Zuhal Yeşilbağ, Emine Karakuş |
| 9 |
[GO] |
2024―Jul―22 |
CXCL12/CXCR4 as a potential axis in diagnosis and predicting disease severity in COVID-19 patients: a new perspective |
Alev Lazoğlu Ozkaya, Esra Laloğlu, Albulhakim Hasan Gul, Neslihan Çelik |
| 10 |
[GO] |
2024―Mai―28 |
Investigation of the effect of low-power, low-frequency ultrasound application on SARS-COV-2 |
Orhan Canbolat, Fatih Canbolat, Mehmet Ali Ergün, Selin Yiğit, Gülendam Bozdayı |
| 11 |
[GO] |
2024―Mai―23 |
Effectiveness after immunization with BNT162b2 and Gam-COVID-Vac for SARS-CoV-2 and neutralizing antibody titers in health care workers |
Melda Emin, Dragan Cibrev, Coskun Kerala, Dragana Petrovska-Cvetkovska, Valdrina Ajeti, Hristina Ampova, Irena Kostovska, Katerina Tosheska-Trajkovska |
| 12 |
[GO] |
2024―Mai―17 |
Does COVID-19 infection alter serum biochemical and hematological biomarkers in deceased dementia patients? |
Duygu Aydemir, Muammer Yucel, Mehmet Koseoglu, Nuriye Nuray Ulusu |
| 13 |
[GO] |
2024―Apr―24 |
Activity of protein C, protein S and antithrombin 3 in COVID-19 patients treated with different modalities of oxygen supplementation |
Šavuk Ana, Grizelj Danijela, Svaguša Tomo, Čulo Melanie-Ivana, Zagorec Nikola, Šakota Sara, Orehovec Biserka, Kelava Tomislav, Livun Ana, Marković Ivan, Baković Josip, Kereš Tatjana |
| 14 |
[GO] |
2024―Feb―28 |
Comparison of efficacy and reliability of six commercial COVID-19 diagnostic PCR kits |
Parisa Sharafi, F. Seyma Gokdemir, Mesut Akyol, Yasemin Ardicoglu-Akisin, J. Sedef Gocmen, Aysegul Taylan-Ozkan |
| 15 |
[GO] |
2024―Feb―14 |
Flow cytometric analysis of lymphocyte subsets, monocytes, and HLA-DR expressions on these cells in patients with COVID-19 |
Nurgul Ozcan, Murat Caglayan, Ali Yalcindag, Oguzhan Ozcan |
| 16 |
[GO] |
2024―Feb―13 |
Does COVID-19 affect thyroid more than non-COVID-19 infections? A retrospective study |
Yasemin Ucal, Muhittin Serdar, Hande Karpuzoğlu, Neval Yurttutan Uyar, Meltem Kilercik, Mustafa Serteser, Aysel Ozpinar |
| 17 |
[GO] |
2023―Sep―12 |
Rhesus factor is a stronger predictor for the risk of Sars-CoV-2 and mortality than ABO blood types |
Soner Yesilyurt, Osman Erinc, Almila Senat, Cem Tugrul Gezmis, Mustafa Bahadir Can Balci |
| 18 |
[GO] |
2023―Jul―26 |
A case of concomitant leukemoid reaction and mucormycosis in a patient with severe COVID-19 infection |
Rand Sayed Issa, Gohar Mushtaq, Aziz Unnisa, Abdo Mahli |
| 19 |
[GO] |
2023―Jun―22 |
Relationship of Thrombospondin-1 and Thrombospondin-2 with hematological, biochemical and inflammatory markers in COVID-19 patients |
Serdar Dogan, Hamza Malik Okuyan, Tayibe Bal, Mehmet Çabalak, Mehmet A. Begen |
| 20 |
[GO] |
2023―Jun―10 |
Investigation of SARS-CoV-2 in vaginal secretions of women with coronavirus disease 2019 |
Esengül Türkyilmaz, Metin Özsoy, Merve Didem Eşkin Tanriverdi, Bedia Dinç, Sibel Aydogan, Özlem Moraloğlu Tekin |
| 21 |
[GO] |
2023―Apr―04 |
Prognostic value of total thiol and D-dimer in patients hospitalized with COVID-19 |
Didem Barlak Keti, Sabahattin Muhtaroglu, Orhan Yildiz, Hatice Saraçoglu |
| 22 |
[GO] |
2022―Okt―11 |
Could tear be an alternative specimen for SARS-CoV-2 detection? |
Yasemin Fatma Cetinkaya, Tugrul Hosbul, Cumhur Artuk, Ceren Karacaylı, Fatih Bakir |
| 23 |
[GO] |
2022―Okt―01 |
The relationship between plasminogen activator Inhibitor-1 levels and the course of disease in COVID-19 patients |
Ecem Baltan, Erdinç Serin, Burak Yasin Avci, Işil Kibar Akilli, Ayşe Sürhan Çinar |
| 24 |
[GO] |
2022―Sep―10 |
The importance of LDH/Albumin, LDH/Lymphocyte, and LDH/Platelet ratios in the evaluation of COVID-19 B.1.1.7 variant |
Gamze Avcioglu, Yavuz Otal, Fadime Gullu Haydar |
| 25 |
[GO] |
2022―Aug―16 |
The relationship between serum vitamin D and antibody response following two doses of inactivated COVID-19 vaccine |
Reyhan Öztürk, Niyazi Samet Yılmaz, Mustafa Ulukanlıgil |
| 26 |
[GO] |
2022―Jul―12 |
The D allele of angiotensin-converting enzyme gene insertion/deletion polymorphism is associated with the lung involvement in COVID-19 |
Fatma Emel Kocak, Raziye Akcilar, Fatih Kar, Ozben Ozden Isiklar, Sahinde Atlanoglu, Ozlem Genc, Fatima Yaman |
| 27 |
[GO] |
2022―Jun―17 |
Early creatinine and e-GFR changes as prognostic predictors of COVID-19 patients |
Karatas Ahmet, Canakci Ebru, Erdem Emre, Ozturan Aykut, Kaya Yasemin, Sayim Beyza, Kaya Mervegul |
| 28 |
[GO] |
2022―Jan―27 |
Neutralizing antibody response and associated factors in Coronavirus-19 disease (COVID-19) up to one month |
Aliye Bastug, Hurrem Bodur, Urartu Ozgur Safak Seker, Nazlican Filazi, Omer Aydos, Ebru Sahin Kehribar, Ali Reza Hanifehnezhad, Sumeyye Kazancioglu, Recep Erdem Ahan, Volkan Aslan, Banu Cakir, Ahmet Sertcelik, Aykut Ozkul |
| 29 |
[GO] |
2021―Dez―23 |
Overview of COVID-19’s relationship with thrombophilia proteins |
Suna Aydin, Kader Ugur, Hanifi Yalcin, İbrahim Sahin, Ramazan Fazil Akkoc, Burkay Yakar, Dogan Yucel, Suleyman Aydin |
| 30 |
[GO] |
2021―Okt―21 |
COVID-19 pandemic reflections in philately |
Mehtap Pekesen, Ahmet Doğan Ataman, Elif Vatanoğlu-Lutz |
| 31 |
[GO] |
2021―Okt―11 |
Could IL-6 predict the clinical severity of COVID-19? |
Guzin Aykal, Hatice Esen, Derya Seyman, Tuğba Çalışkan |
| 32 |
[GO] |
2021―Aug―21 |
A cross-sectional overview of SARS-CoV-2 genome variations in Turkey |
Koray Ergünay, Mücahit Kaya, Muhittin Serdar, Yakut Akyön, Engin Yılmaz |
| 33 |
[GO] |
2021―Aug―18 |
Comparison of biochemical and immunological biomarker levels of patients with COVID-19 with healthy individuals |
Ugur Ercin, Emel Turk Aribas, Semra Tuncbilek, Canturk Kaya, Aylin Sepici Dincel, Ayse Bilgihan, Mehmet Emin Tekeli |
| 34 |
[GO] |
2021―Aug―11 |
Oxidative stress index can be a new marker related to disease severity in COVID-19 |
Serdar Doğan, Tayibe Bal, Mehmet Çabalak, Nursel Dikmen, Hasibullah Yaqoobi, Oguzhan Ozcan |
| 35 |
[GO] |
2021―Jul―13 |
Immature platelet fraction: is a novel early predictive marker for disease severity in patients with Covid-19 pneumonia? |
Said Incir, Zeynep Komesli, Arzu Baygul, Zeynep Atam Tasdemir, Kerim Erhan Palaoglu, Hatice Kant, Mahir Kapmaz, Suda Tekin, Alparslan Kilic, Tuncay Dagel, Ayse Okan, Kayra Somay, Timur Selcuk Akpinar |
| 36 |
[GO] |
2021―Jun―18 |
Serum microRNA signature is capable of predictive and prognostic factor for SARS-COV-2 virulence |
Aydın Demiray, Tuğba Sarı, Ahmet Çalışkan, Rukiye Nar, Levent Aksoy, İsmail Hakkı Akbubak |
| 37 |
[GO] |
2021―Feb―05 |
The use of laboratory parameters and computed tomography score to determine intensive care unit requirement in COVID-19 |
Halef Okan Doğan, Serkan Bolat, Seyit Ali Büyüktuna, Rağıp Sarıismailoğlu, Nazım Çetinkaya, Kübra Doğan, Mürşit Hasbek, Halil Çaylak |
| 38 |
[GO] |
2021―Feb―05 |
A notable key for estimating the severity of COVID-19: 25-hydroxyvitamin D status |
Merve Ergin Tuncay, Emin Gemcioglu, Bircan Kayaaslan, Ihsan Ates, Rahmet Guner, Fatma Eser, Imran Hasanoglu, Ayse Kaya Kalem, Adalet Aypak, Zubeyr Said Agac, Serife Gokbulut Bektas, Ibrahim Mungan, Ahmet Gokhan Akdag, Seval Izdes, Salim Neselioglu, Ozcan Erel |
| 39 |
[GO] |
2021―Jan―14 |
Genetic and epigenetic concept of SARS-CoV-2 targets in different renal cancer subtypes |
Dilara Fatma Akin-Bali, Rahşan Ilikci Sagkan |
| 40 |
[GO] |
2020―Dez―22 |
Hookah use and COVID-19 |
Yasemin Ardicoglu Akisin, Salih Erpulat Ozis, Mustafa Baris Poyraz, Halil Kurt |
| 41 |
[GO] |
2020―Dez―05 |
Lymphocyte-to-C-reactive protein ratio may serve as an effective biomarker to determine COVID-19 disease severity |
Tayibe Bal, Serdar Dogan, Mehmet Cabalak, Emre Dirican |
| 42 |
[GO] |
2020―Dez―05 |
Therapeutic approaches on the interaction between SARS-CoV2 and ACE2: a biochemical perspective |
Gulden Baskol, Mumtaz M. Mazicioglu, Merve Özel |
| 43 |
[GO] |
2020―Nov―30 |
Therapeutic agents currently employed against Covid-19: an effort to control the pandemic |
Diana Matías-Pérez, Alma Dolores Pérez-Santiago, Marco Antonio Sánchez-Medina, Iván Antonio García-Montalvo |
| 44 |
[GO] |
2020―Nov―03 |
Value of blood IFN-I levels in COVID-19 management |
Burak Arslan, Aylin Sepici Dinçel |
| 45 |
[GO] |
2020―Sep―25 |
COVID-19 laboratory biosafety guide |
Oğuzhan Zengi, Guzin Aykal, Cihan Coskun, Muhittin Serdar, Dogan Yucel |
| 46 |
[GO] |
2020―Sep―07 |
Assessment of the frequency and biochemical parameters of conjunctivitis in COVID-19 and other viral and bacterial conditions |
Yavuz Oruc, Suleyman Aydin, Ramazan Fazil Akkoc, Suna Aydin, Fatih Cem Gul, Kader Ugur, İbrahim Sahin, Onur Hanbeyoglu, Suleyman Sirri Kilic, Aziz Aksoy |
| 47 |
[GO] |
2020―Sep―07 |
High dose ascorbic acid treatment in COVID-19 patients raised some problems in clinical chemistry testing |
Fatih Yesildal, Ferruh Kemal Isman |
| 48 |
[GO] |
2020―Aug―28 |
The molecular footprints of COVID-19 |
Engin Yilmaz, Yakut Akyön, Muhittin Serdar |
| 49 |
[GO] |
2020―Aug―28 |
The role of biotin metabolism in the COVID-19 infection |
Duygu Aydemir, Nuriye Nuray Ulusu |
| 50 |
[GO] |
2020―Aug―17 |
Newly developed diagnostic methods for SARS-CoV-2 detection |
Ebru Saatçi |
| 51 |
[GO] |
2020―Jul―10 |
The effect of COVID-19 pandemic on biochemistry laboratory test consumption numbers and variety |
Muammer Yucel, Candeger Avsar |
